Posts by tag: biomarker-discovery

Dr. Henri Huttunen from Herantis Pharma shares his experiences with our Virtual Bioinformatics Core service

Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies

Learn how Amazentis leveraged omics analyses in a clinical trial for a postbiotic

Learn about Genevia Technologies' work with a research group studying the epigenetics of pain

Learn how machine learning enables risk stratification using high-throughput data

Learn how machine learning enables personalized clinical predictions

Learn how Genevia Technologies helped with FastEV's commercialization.

Learn about how KCT identified new biomarkers for a macrophage subtype of their interest.